The Indian pharmaceutical market achieved a 7.8% growth in April 2025, with sales reaching Rs 19,711 crore, driven by strategic pricing and new product introductions. Specialty the...
Amgen Inc. announced a 9% revenue increase to $8.1 billion in Q1 2025, surpassing estimates with a net income of $1.7 billion. CEO Robert Bradway highlights strong global demand an...
Amgen Inc. reports a 9% revenue increase to $8.1 billion in Q1 2025, with GAAP net income reaching $1.7 billion. CEO Robert Bradway highlights strong global demand and successful p...
Eli Lilly's first quarter revenue jumps 45% to $12.73 billion, driven by Mounjaro and Zepbound. Net income rises 23% to $2.76 billion, with EPS at $3.06. Plans for a $50 billion US...
Eli Lilly's first-quarter revenue for fiscal 2025 soared by 45% to $12.73 billion, thanks to the strong performance of Mounjaro and Zepbound. The company also reported a 23% increa...
AstraZeneca announces a 7% revenue increase to $13.6 billion in Q1 2025, with product sales up by 6% and core operating profit growing by 12%. The company forecasts continued growt...
AstraZeneca PLC announced a 7% revenue increase to $13.6 billion in Q1 2025, with product sales up by 6%. The company forecasts continued growth, aiming for $80 billion in total re...
AstraZeneca announces a 7% revenue growth to $13.6 billion in Q1 2025, with product sales up by 6% and core operating profit increasing by 12%. The company forecasts continued grow...
Roche AG kicks off 2025 with a 6% sales increase in Q1, driven by an 8% growth in pharmaceuticals. CEO Schinecker outlines a $50 billion US expansion plan to innovate healthcare so...
Roche AG kicks off fiscal 2025 with a 6% increase in Q1 sales to 15.4 billion Swiss francs, driven by an 8% growth in pharmaceuticals. CEO Schinecker outlines ambitious US expansio...
Novartis AG reported a 15% increase in Q4 net sales to $13.15 billion, with a 7% rise in net income to $2.82 billion. The company's full-year net sales reached $50.32 billion, up 1...
